Stocklytics Platform
Asset logo for symbol FENC
Fennec Pharmaceuticals
FENC64
$6.63arrow_drop_up0.07%$0.00
Asset logo for symbol FENC
FENC64

$6.63

arrow_drop_up0.07%
Key Stats
Open$6.65
Prev. Close$6.66
EPS-0.04
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$182.42M
PE Ratio-
LOWHIGH
Day Range6.51
6.89
52 Week Range3.80
11.92
Ratios
EPS-0.04
Fundamentals
Debt/Equity Ratio-
Payout Ratio-
Industry average yield3.25%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

FENC-
US Healthcare Sector-
US Market-
check_circle

FENC / Market

FENC exceeded the US Market which returned -0.68% over the last twenty four hours.
warning

FENC / Healthcare Sector

FENC lose to the US Healthcare sector which returned 1.01% over the last twenty four hours.

Fennec Pharmaceuticals (FENC) Statistics

Fennec Pharmaceuticals Inc (FENC) is a pharmaceutical company specializing in the development of innovative cancer therapies. With a focus on improving the lives of patients with rare forms of cancer, Fennec is dedicated to delivering high-quality treatments that address unmet medical needs. As a leader in the field of oncology, the company is committed to advancing the understanding and treatment of cancer through its cutting-edge research and development efforts.
When it comes to Fennec Pharmaceuticals Inc's valuation metrics, investors can look at a range of indicators to gain insight into the company's financial health. These metrics include market capitalization, price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio. By analyzing these metrics, investors can assess the company's value relative to its earnings, sales, and assets. Fennec Pharmaceuticals Inc's valuation metrics provide valuable information for investors looking to make informed investment decisions.
add Fennec Pharmaceuticals  to watchlist

Keep an eye on Fennec Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Fennec Pharmaceuticals (FENC) stock's performance compared to its sector and the market over the past year?

Over the past year, Fennec Pharmaceuticals (FENC) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 19.05%, Fennec Pharmaceuticals has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 43.77%, it has fallen short of the market average. This comparison highlights Fennec Pharmaceuticals 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Fennec Pharmaceuticals (FENC) stock?

The PE ratio for Fennec Pharmaceuticals (FENC) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Fennec Pharmaceuticals (FENC) stock?

The Earnings Per Share (EPS) for Fennec Pharmaceuticals (FENC), calculated on a diluted basis, is -$0.04. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Fennec Pharmaceuticals (FENC) stock?

The operating margin for Fennec Pharmaceuticals (FENC) is -74.59%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Fennec Pharmaceuticals (FENC) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Fennec Pharmaceuticals (FENC) is $0. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Fennec Pharmaceuticals (FENC) have?

Fennec Pharmaceuticals (FENC) has a total debt of $32.1M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$8.22M.

Take Your Investments to a Whole New Level